Infection control experience in a cooperative care center for transplant patients

Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America
Ahmad NusairMark E Rupp

Abstract

To characterize infection control experience during a 6.5-year period in a cooperative care center for transplant patients. Descriptive analysis. A cooperative care center for transplanted patients, in which patients and care partners are housed in a homelike environment, and care partners assume responsibility for patient care duties. Nine hundred ninety one transplant patients. Infection control definitions from the Centers for Disease Control and Prevention were used to ascertain infection rates. Environmental cultures were used to detect methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus (VRE), Clostridium difficile, and fungi during the first 18 months. Surveillance cultures were performed for a subset of patients and care partners. From June 1999 through December 2005, there were 19,365 patient-days observed. The most common healthcare-associated infection encountered was intravascular catheter-related bloodstream infection, with infection rates of 5.74 and 4.94 cases per 1,000 patient-days for hematopoietic stem cell transplant (HSCT) and solid organ transplant (SOT) patients, respectively. C. difficile-associated diarrhea was observed more frequently in HSCT patients than in SOT patien...Continue Reading

References

Sep 1, 1989·Journal of Clinical Microbiology·P C IwenG L Woods
Jan 1, 1996·Patient Education and Counseling·T FrancoG R Woscyna
Dec 24, 1997·Liver Transplantation and Surgery : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·E A DominguezM E Rupp
Feb 15, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·N SinghI R Marino
Jan 11, 2001·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·R PatelR L Thompson
Jun 6, 2003·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Carlene A MutoUNKNOWN SHEA
Nov 8, 2003·Clinical Journal of Oncology Nursing·Kim Schmit-PokornyRuth Caddy Vyhlidal
Jan 9, 2004·Clinics in Laboratory Medicine·Paul D Fey, Mark E Rupp
Jul 2, 2005·Oncology Nursing Forum·June EilersSue Knutson
May 8, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Mark E RuppJames R Anderson

❮ Previous
Next ❯

Citations

Nov 27, 2010·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Shawna KraftDaryl D DePestel
Oct 28, 2008·The Journal of Antimicrobial Chemotherapy·Federico PeaMario Furlanut
Dec 20, 2011·The Journal of Infection·Paul J ColliniDavid H Dockrell
Jan 28, 2010·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·P Muñoz, UNKNOWN AST Infectious Diseases Community of Practice
Apr 3, 2012·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Elisa Teixeira MendesSilvia Figueiredo Costa

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.